Page last updated: 2024-10-29

indirubin-3'-monoxime and Constriction, Pathological

indirubin-3'-monoxime has been researched along with Constriction, Pathological in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwaiberger, AV1
Heiss, EH1
Cabaravdic, M1
Oberan, T1
Zaujec, J1
Schachner, D1
Uhrin, P1
Atanasov, AG1
Breuss, JM1
Binder, BR1
Dirsch, VM1

Other Studies

1 other study available for indirubin-3'-monoxime and Constriction, Pathological

ArticleYear
Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
    Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:12

    Topics: Animals; Arterial Occlusive Diseases; Becaplermin; Cell Cycle; Cell Proliferation; Cells, Cultured;

2010